Matches in Wikidata for { <http://www.wikidata.org/entity/Q91854209> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q91854209 description "2019 թվականի հուլիսի 11-ին հրատարակված գիտական հոդված" @default.
- Q91854209 description "artículu científicu espublizáu en xunetu de 2019" @default.
- Q91854209 description "scientific article published on 11 July 2019" @default.
- Q91854209 description "wetenschappelijk artikel" @default.
- Q91854209 description "наукова стаття, опублікована 11 липня 2019" @default.
- Q91854209 name "First clinical trials of novel ENaC targeting therapy, SPX-101, in healthy volunteers and adults with cystic fibrosis" @default.
- Q91854209 name "First clinical trials of novel ENaC targeting therapy, SPX-101, in healthy volunteers and adults with cystic fibrosis" @default.
- Q91854209 type Item @default.
- Q91854209 label "First clinical trials of novel ENaC targeting therapy, SPX-101, in healthy volunteers and adults with cystic fibrosis" @default.
- Q91854209 label "First clinical trials of novel ENaC targeting therapy, SPX-101, in healthy volunteers and adults with cystic fibrosis" @default.
- Q91854209 prefLabel "First clinical trials of novel ENaC targeting therapy, SPX-101, in healthy volunteers and adults with cystic fibrosis" @default.
- Q91854209 prefLabel "First clinical trials of novel ENaC targeting therapy, SPX-101, in healthy volunteers and adults with cystic fibrosis" @default.
- Q91854209 P1433 Q91854209-8C02A89B-632E-42EA-BA19-FAF2590B404E @default.
- Q91854209 P1476 Q91854209-A0A9B39A-D7CE-437E-A9A8-5D2BA0EE29B7 @default.
- Q91854209 P2093 Q91854209-4DD7CBE9-FA34-442F-9C91-CDB40FB324F7 @default.
- Q91854209 P2093 Q91854209-667C1FE0-209F-4D57-8725-99A82E91E3B4 @default.
- Q91854209 P2093 Q91854209-6777A680-C230-4548-9C1F-FC9E4659F24C @default.
- Q91854209 P2093 Q91854209-79BDDB9A-4683-42C2-A89A-7BEF1A8DB6B4 @default.
- Q91854209 P2093 Q91854209-7ECE73DB-9175-475E-81AA-F144BA48166E @default.
- Q91854209 P2093 Q91854209-97103997-6A9F-496B-85D1-2D7F24CD82DB @default.
- Q91854209 P2093 Q91854209-E31AC28B-2910-4B56-8AED-894C465E2C8A @default.
- Q91854209 P2093 Q91854209-F29D4803-EA16-42A7-9480-BD448274D080 @default.
- Q91854209 P304 Q91854209-387F6F38-C5E0-4DB1-A0B4-6ACA41C7849C @default.
- Q91854209 P31 Q91854209-F2C720DC-60EF-4904-BFF9-FC2294EE8837 @default.
- Q91854209 P356 Q91854209-D4E0E0DF-29B8-459A-B1AA-1646F5D0B1F4 @default.
- Q91854209 P478 Q91854209-8C5DEDBD-888A-4C44-B757-D39E0146BAB4 @default.
- Q91854209 P577 Q91854209-76A09729-5085-4B47-8804-340F847B2D69 @default.
- Q91854209 P698 Q91854209-4E2F1B97-9CCB-43ED-B24F-61CD69BDB150 @default.
- Q91854209 P921 Q91854209-4D7614F2-CEB5-4391-A6A6-9477596552A8 @default.
- Q91854209 P356 J.PUPT.2019.101819 @default.
- Q91854209 P698 31302339 @default.
- Q91854209 P1433 Q7259517 @default.
- Q91854209 P1476 "First clinical trials of novel ENaC targeting therapy, SPX-101, in healthy volunteers and adults with cystic fibrosis" @default.
- Q91854209 P2093 "Christie Hudson" @default.
- Q91854209 P2093 "Elizabeth Tullis" @default.
- Q91854209 P2093 "Katherine Griffin" @default.
- Q91854209 P2093 "Leena Rizvi" @default.
- Q91854209 P2093 "Paulina Farias" @default.
- Q91854209 P2093 "Peter Couroux" @default.
- Q91854209 P2093 "Robert Tarran" @default.
- Q91854209 P2093 "Timothy Crowder" @default.
- Q91854209 P304 "101819" @default.
- Q91854209 P31 Q13442814 @default.
- Q91854209 P356 "10.1016/J.PUPT.2019.101819" @default.
- Q91854209 P478 "58" @default.
- Q91854209 P577 "2019-07-11T00:00:00Z" @default.
- Q91854209 P698 "31302339" @default.
- Q91854209 P921 Q178194 @default.